Literature DB >> 22907839

Outcomes of observation as therapy for pelvic organ prolapse: a study in the natural history of pelvic organ prolapse.

Alienor S Gilchrist1, William Campbell, Hannah Steele, Hema Brazell, Jonathon Foote, Steven Swift.   

Abstract

AIMS: To determine the rate of progression or regression of pelvic organ prolapse (POP) in subjects with symptomatic POP who decline intervention (pessary or surgery) and elect observation.
METHODS: Sixty-four patients choosing observation as primary management of symptomatic POP were followed with sequential pelvic organ prolapse quantification (POP-Q) exams. A change in the leading edge value of ±≥2 cm was considered significant. POP-Q exam results, choice of therapy and symptom severity at last visit were recorded.
RESULTS: The leading vaginal edge POP-Q exam value at initial exam ranged from -1.5 to 7 cm. Distribution of patients by POP-Q stages on initial exam was: stage I: 1%, stage II: 31%, stage III: 31%, and stage IV: 1.78% (50/64) of patients demonstrated no change in leading edge value from first to last visit on POP-Q exams. Nineteen percent (12/64) demonstrated progression (≥2 cm increase in leading edge); 3% (2/64) demonstrated regression (≥2 cm decrease in leading edge). Median follow-up was 16 months (range 6-91 months). On multivariate analysis, no variable, including length of follow-up, was associated with change in leading edge value (P = 0.09, data not shown). At their last recorded visit, 63% (40/64) of subjects continued observation, 38% (24/64) desired a pessary trial or surgical correction. Those desiring intervention had no greater worsening of prolapse on exam at last follow-up compared with subjects who continued observation.
CONCLUSION: The natural history of pelvic organ prolapse is most often one of very minimal change in subjects who decline intervention (pessary or surgery) and choose observation.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22907839     DOI: 10.1002/nau.22298

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  9 in total

1.  Natural history of pelvic organ prolapse in symptomatic patients actively seeking treatment.

Authors:  Javier Pizarro-Berdichevsky; Ali Borazjani; Alejandro Pattillo; Marco Arellano; Jianbo Li; Howard B Goldman
Journal:  Int Urogynecol J       Date:  2017-08-24       Impact factor: 2.894

2.  Factors affecting patient choice for continued observation versus intervention for pelvic organ prolapse.

Authors:  Marieme Mbaye; L Autumn Edenfield; Abbigail Woll; Steven E Swift
Journal:  Int Urogynecol J       Date:  2020-07-28       Impact factor: 2.894

Review 3.  International urogynecology consultation chapter 1 committee 2: Epidemiology of pelvic organ prolapse: prevalence, incidence, natural history, and service needs.

Authors:  Heidi W Brown; Aparna Hegde; Markus Huebner; Hedwig Neels; Hayley C Barnes; Gisele Vissoci Marquini; Narmin Mukhtarova; Bernard Mbwele; Visha Tailor; Ervin Kocjancic; Elisa Trowbridge; Lynsey Hayward
Journal:  Int Urogynecol J       Date:  2022-01-03       Impact factor: 2.894

Review 4.  Rare complications of pessary use: A systematic review of case reports.

Authors:  Stefan Dabic; Christina Sze; Stephanie Sansone; Bilal Chughtai
Journal:  BJUI Compass       Date:  2022-07-05

5.  Pelvic organ prolapse in a cohort of women treated for stress urinary incontinence.

Authors:  Peggy Norton; Linda Brubaker; Charles W Nager; Gary E Lemack; Halina M Zyczynski; Larry Sirls; Leslie Rickey; Anne Stoddard; R Edward Varner
Journal:  Am J Obstet Gynecol       Date:  2014-08-01       Impact factor: 8.661

6.  Patient characteristics associated with treatment choice for pelvic organ prolapse and urinary incontinence.

Authors:  Stephanie A Sullivan; Emily R W Davidson; C Emi Bretschneider; Abigail L Liberty; Elizabeth J Geller
Journal:  Int Urogynecol J       Date:  2015-12-07       Impact factor: 2.894

7.  Recurrence risk is associated with preoperatively advanced prolapse stage: Is there a difference between women with stage 2 and those with stage 3 or 4 cystocele?

Authors:  Tineke F M Vergeldt; Kim J B Notten; Kirsten B Kluivers; Mirjam Weemhoff
Journal:  Int Urogynecol J       Date:  2016-12-06       Impact factor: 2.894

Review 8.  A guide for urogynecologic patient care utilizing telemedicine during the COVID-19 pandemic: review of existing evidence.

Authors:  Cara L Grimes; Ethan M Balk; Catrina C Crisp; Danielle D Antosh; Miles Murphy; Gabriela E Halder; Peter C Jeppson; Emily E Weber LeBrun; Sonali Raman; Shunaha Kim-Fine; Cheryl Iglesia; Alexis A Dieter; Ladin Yurteri-Kaplan; Gaelen Adam; Kate V Meriwether
Journal:  Int Urogynecol J       Date:  2020-04-27       Impact factor: 2.894

9.  Effect of Pelvic Floor Workout on Pelvic Floor Muscle Function Recovery of Postpartum Women: Protocol for a Randomized Controlled Trial.

Authors:  Hongmei Zhu; Di Zhang; Lei Gao; Huixin Liu; Yonghui Di; Bing Xie; Wei Jiao; Xiuli Sun
Journal:  Int J Environ Res Public Health       Date:  2022-09-04       Impact factor: 4.614

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.